Study of clinical characteristics of acute stroke with COVID-19

Study of clinical characteristics of acute stroke with COVID-19 - Study of acute stroke with COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041226

Enrollment

100

Registered

2020-07-27

Start date

2020-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with acute stroke in confirmed COVID-19 2) Positive results for COVID-19 based on reverse transcriptase-polymerase chain reaction (RT-PCR) after patients were admitted with acute stroke (including hospital-acquired infection)

Exclusion criteria

Exclusion criteria: Patients judged as inappropriate for this study by investigators

Design outcomes

Primary

Measure	Time frame
The clinical characteristics of patients with acute stroke for confirmed COVID-19	—

Secondary

Measure	Time frame
History, medications administered at admission (onset for hospital-onset patients), specific treatment for COVID-19, data at admission, laboratory values (at admission), pneumonia at stroke onset, ventilator (including Bipap) use, ECMO use, stroke characteristics, details of revascularization procedures, outcome	—

Countries

Japan

Contacts

Public ContactYasuhiro Nishiyama

Nippon Medical School department of neurology

nomo16@nms.ac.jp0338222131

Outcome results